Loading…
CIK 0002043476 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("b-group-inc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ADMA BIOLOGICS INC | COM | $44.8M | 33.1%Prev: 26.0% | 2,457,542 SH | Increased+45,000 SH |
| APOGEE THERAPEUTICS INC | COM | $1.5M | 1.1%Prev: 1.0% | 20,000 SH | Increased-15,000 SH |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $6.0M | 4.4%Prev: 3.3% | 175,706 SH | Increased |
| AURA BIOSCIENCES INC | COM | $3.1M | 2.3%Prev: 2.6% | 572,576 SH | Decreased |
| CELLECTIS S A | SPON ADS | $15.9M | 11.7%Prev: 6.9% | 3,281,501 SH | Increased |
| IOVANCE BIOTHERAPEUTICS INC | COM | $4.1M | 3.0%Prev: 2.4% | 1,500,000 SH | Increased |
| ORUKA THERAPEUTICS INC | COM | $2.3M | 1.7%Prev: 1.1% | 75,000 SH | Increased |
| PALISADE BIO INC | COM | $10.6M | 7.8% | 4,500,000 SH | New |
| PRAXIS PRECISION MEDICINES I | COM NEW | $9.8M | 7.2%Prev: 1.2% | 33,237 SH | Increased+1,737 SH |
| REPLIMUNE GROUP INC | COM | $486K | 0.4%Prev: 0.2% | 50,000 SH | Increased |
| SIGHT SCIENCES INC | COM | $7.3M | 5.4%Prev: 2.4% | 920,000 SH | Increased-10,000 SH |
| SPYRE THERAPEUTICS INC | COM NEW | $3.3M | 2.4%Prev: 1.2% | 100,000 SH | Increased |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $6.3M | 4.6% | 90,000 SH | New |
| TAYSHA GENE THERAPIES INC | COM SHS | $9.9M | 7.3%Prev: 4.3% | 1,800,556 SH | Increased |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $3.1M | 2.3%Prev: 3.0% | 135,000 SH | Decreased |
| ZAI LAB LTD | ADR | $7.1M | 5.2%Prev: 10.0% | 400,000 SH | Decreased |
| 13F-HR |
| 0001420506-26-001657 |
| $213.0M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001420506-25-002005 | $129.9M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001420506-26-001023 | $134.9M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001420506-25-001152 | $116.7M | View |